Japan Intellectual Property Rights: AUTO/ALLO-IMMUNE DEFENSE RECEPTORS FOR SELECTIVE TARGETING OF ACTIVATED PATHOGENIC T CELLS AND NK CELLS

Japan, April 14 -- BAYLOR COLLEGE OF MEDICINE has got intellectual property rights for 'AUTO/ALLO-IMMUNE DEFENSE RECEPTORS FOR SELECTIVE TARGETING OF ACTIVATED PATHOGENIC T CELLS AND NK CELLS.' Other related details are as follows:

Application Number: JP,2024-188785

Category (FI): A61K35/12,A61K35/17,A61K40/11,A61K40/22,A61K40/30,A61K40/31,A61K40/32,A61K40/50,A61P1/04,A61P25/00,A61P3/10,A61P37/06,A61P43/00,105,C07K14/47,C07K14/705,C07K14/725,C07K16/00,C07K19/00,C12N15/09,100,C12N15/12,C12N15/13,C12N15/62@Z,C12N15/63@Z,C12N15/861@Z,C12N15/864,100@Z,C12N15/867@Z,C12N5/0783,C12N5/10

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Oct. 28, 2024

Publication Date: March 18, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.